BRIDGET: Preventing Secondary Brain Metastases in Advanced HER2+ Breast Cancer

Opinion
Video

Carey Anders, MD, offers insights into the BRIDGET trial, a study investigating the role of tucatinib in the prevention of secondary brain metastases in patients with advanced HER2-positive breast cancer.

Recent Videos
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.
Related Content
3 Intraoperative Radiotherapy: Alive and Well in the Bronx

3 Intraoperative Radiotherapy: Alive and Well in the Bronx

Caroline Oska;Eleni Kohilakis;Jana Fox
July 15th 2025
Article
Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
April 21st 2025
Podcast

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

4 Evaluating AI-Driven Responses in Breast Reconstruction: A Comparative Study of Response Formats

4 Evaluating AI-Driven Responses in Breast Reconstruction: A Comparative Study of Response Formats

Tarbia Hamid;Laura Manfroi;Hiral Thakkar;Samir Mitri
July 14th 2025
Article
Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care

Paolo Tarantino, MD, PhD;Matteo Lambertini, MD
January 13th 2025
Podcast

Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

6 Peer Support Programming Among Women At-Risk for Surviving Breast Cancer: Facilitators and Barriers to Community-Based Patient Navigation and the Role of Quality of Life

6 Peer Support Programming Among Women At-Risk for Surviving Breast Cancer: Facilitators and Barriers to Community-Based Patient Navigation and the Role of Quality of Life

Muriel Statman;Marcelo Sleiman Jr;Duye Liu;Anthony Zisa;Adina Fleischmann;Kenneth Tercyak
July 12th 2025
Article
Use of TumorSight Viz may support improved consistency, precision, and efficiency in breast cancer surgery.

FDA Clears AI-Based Visualization Software for Surgical Breast Cancer Care

Russ Conroy
July 12th 2025
Article

Use of TumorSight Viz may support improved consistency, precision, and efficiency in breast cancer surgery.